vs
Doximity, Inc.(DOCS)与如新(NUS)财务数据对比。点击上方公司名可切换其他公司
如新的季度营收约是Doximity, Inc.的1.7倍($320.6M vs $185.1M),Doximity, Inc.净利率更高(33.3% vs 0.6%,领先32.7%),Doximity, Inc.同比增速更快(9.8% vs -12.0%),过去两年Doximity, Inc.的营收复合增速更高(25.2% vs -14.5%)
Doximity Inc成立于2010年,是面向医疗专业人士的线上社交服务平台,为平台会员提供精选医疗资讯、远程医疗工具,以及病例协作相关功能,助力医疗从业者高效交流信息、开展诊疗相关工作。
如新企业集团是一家美国多层次直销企业,主打研发并销售个人护理产品与营养膳食补充产品,旗下拥有Nu Skin及Pharmanex两大品牌,目前已在全球54个市场开展业务,依托约120万独立销售代表的销售网络覆盖全球市场。
DOCS vs NUS — 直观对比
营收规模更大
NUS
是对方的1.7倍
$185.1M
营收增速更快
DOCS
高出21.8%
-12.0%
净利率更高
DOCS
高出32.7%
0.6%
两年增速更快
DOCS
近两年复合增速
-14.5%
损益表 — Q3 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $185.1M | $320.6M |
| 净利润 | $61.6M | $1.8M |
| 毛利率 | 89.9% | 66.9% |
| 营业利润率 | 38.9% | 34.4% |
| 净利率 | 33.3% | 0.6% |
| 营收同比 | 9.8% | -12.0% |
| 净利润同比 | -18.1% | — |
| 每股收益(稀释后) | $0.31 | $0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DOCS
NUS
| Q1 26 | — | $320.6M | ||
| Q4 25 | $185.1M | $370.3M | ||
| Q3 25 | $168.5M | $364.2M | ||
| Q2 25 | $145.9M | $386.1M | ||
| Q1 25 | $138.3M | $364.5M | ||
| Q4 24 | $168.6M | $445.6M | ||
| Q3 24 | $136.8M | $430.1M | ||
| Q2 24 | $126.7M | $439.1M |
净利润
DOCS
NUS
| Q1 26 | — | $1.8M | ||
| Q4 25 | $61.6M | $14.5M | ||
| Q3 25 | $62.1M | $17.1M | ||
| Q2 25 | $53.3M | $21.1M | ||
| Q1 25 | $62.5M | $107.5M | ||
| Q4 24 | $75.2M | $-36.1M | ||
| Q3 24 | $44.2M | $8.3M | ||
| Q2 24 | $41.4M | $-118.3M |
毛利率
DOCS
NUS
| Q1 26 | — | 66.9% | ||
| Q4 25 | 89.9% | 70.7% | ||
| Q3 25 | 90.3% | 70.5% | ||
| Q2 25 | 89.2% | 68.8% | ||
| Q1 25 | 89.5% | 67.8% | ||
| Q4 24 | 91.6% | 62.7% | ||
| Q3 24 | 90.0% | 70.1% | ||
| Q2 24 | 89.3% | 70.0% |
营业利润率
DOCS
NUS
| Q1 26 | — | 34.4% | ||
| Q4 25 | 38.9% | 6.3% | ||
| Q3 25 | 37.8% | 5.9% | ||
| Q2 25 | 37.4% | 8.0% | ||
| Q1 25 | 35.2% | -2.7% | ||
| Q4 24 | 47.4% | -11.9% | ||
| Q3 24 | 38.8% | 4.2% | ||
| Q2 24 | 36.4% | -28.6% |
净利率
DOCS
NUS
| Q1 26 | — | 0.6% | ||
| Q4 25 | 33.3% | 3.9% | ||
| Q3 25 | 36.8% | 4.7% | ||
| Q2 25 | 36.5% | 5.5% | ||
| Q1 25 | 45.2% | 29.5% | ||
| Q4 24 | 44.6% | -8.1% | ||
| Q3 24 | 32.3% | 1.9% | ||
| Q2 24 | 32.7% | -26.9% |
每股收益(稀释后)
DOCS
NUS
| Q1 26 | — | $0.04 | ||
| Q4 25 | $0.31 | $0.27 | ||
| Q3 25 | $0.31 | $0.34 | ||
| Q2 25 | $0.27 | $0.43 | ||
| Q1 25 | $0.31 | $2.14 | ||
| Q4 24 | $0.37 | $-0.73 | ||
| Q3 24 | $0.22 | $0.17 | ||
| Q2 24 | $0.21 | $-2.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $64.8M | $198.7M |
| 总债务越低越好 | — | $223.6M |
| 股东权益账面价值 | $979.3M | $794.1M |
| 总资产 | $1.2B | $1.4B |
| 负债/权益比越低杠杆越低 | — | 0.28× |
8季度趋势,按日历期对齐
现金及短期投资
DOCS
NUS
| Q1 26 | — | $198.7M | ||
| Q4 25 | $64.8M | $239.8M | ||
| Q3 25 | $169.2M | $253.0M | ||
| Q2 25 | $137.3M | $265.4M | ||
| Q1 25 | $209.6M | $213.6M | ||
| Q4 24 | $165.3M | $198.0M | ||
| Q3 24 | $184.2M | $237.8M | ||
| Q2 24 | $111.4M | $232.9M |
总债务
DOCS
NUS
| Q1 26 | — | $223.6M | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
DOCS
NUS
| Q1 26 | — | $794.1M | ||
| Q4 25 | $979.3M | $805.2M | ||
| Q3 25 | $1.1B | $799.8M | ||
| Q2 25 | $1.0B | $787.8M | ||
| Q1 25 | $1.1B | $754.0M | ||
| Q4 24 | $1.0B | $651.5M | ||
| Q3 24 | $961.2M | $706.9M | ||
| Q2 24 | $913.6M | $686.2M |
总资产
DOCS
NUS
| Q1 26 | — | $1.4B | ||
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | $1.2B | $1.4B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | $1.1B | $1.6B |
负债/权益比
DOCS
NUS
| Q1 26 | — | 0.28× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $60.9M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.99× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
DOCS
NUS
| Q1 26 | — | — | ||
| Q4 25 | $60.9M | $16.6M | ||
| Q3 25 | $93.9M | $27.5M | ||
| Q2 25 | $62.1M | $35.8M | ||
| Q1 25 | $98.5M | $389.0K | ||
| Q4 24 | $65.2M | $25.8M | ||
| Q3 24 | $68.3M | $31.4M | ||
| Q2 24 | $41.2M | $51.2M |
自由现金流
DOCS
NUS
| Q1 26 | — | — | ||
| Q4 25 | — | $5.9M | ||
| Q3 25 | — | $17.6M | ||
| Q2 25 | — | $35.8M | ||
| Q1 25 | — | $-13.2M | ||
| Q4 24 | — | $13.2M | ||
| Q3 24 | — | $22.8M | ||
| Q2 24 | — | $43.1M |
自由现金流率
DOCS
NUS
| Q1 26 | — | — | ||
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | -3.6% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 9.8% |
资本支出强度
DOCS
NUS
| Q1 26 | — | — | ||
| Q4 25 | — | 2.9% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | 0.0% | 3.7% | ||
| Q4 24 | 0.0% | 2.8% | ||
| Q3 24 | 0.0% | 2.0% | ||
| Q2 24 | 0.0% | 1.9% |
现金转化率
DOCS
NUS
| Q1 26 | — | — | ||
| Q4 25 | 0.99× | 1.15× | ||
| Q3 25 | 1.51× | 1.61× | ||
| Q2 25 | 1.16× | 1.69× | ||
| Q1 25 | 1.58× | 0.00× | ||
| Q4 24 | 0.87× | — | ||
| Q3 24 | 1.55× | 3.79× | ||
| Q2 24 | 1.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCS
| Subscription | $175.4M | 95% |
| Service Other | $9.7M | 5% |
NUS
暂无分部数据